Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Infected”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT00122668
What this trial is testing

Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive Patients

Who this might be right for
HIV InfectionsHIV-Associated Lipodystrophy Syndrome
French National Agency for Research on AIDS and Viral Hepatitis 112
Large-scale testing (Phase 3)Ended earlyNCT01731691
What this trial is testing

Safety and Efficacy of (α1Proteinase Inhibitor, α1PI) in HIV Disease

Who this might be right for
HIV Disease
Institute for Human Genetics and Biochemistry 12
Testing effectiveness (Phase 2)Study completedNCT00109590
What this trial is testing

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 175
Testing effectiveness (Phase 2)Ended earlyNCT00090779
What this trial is testing

Nine Month Course of Anti-HIV Medications for People Recently Infected With HIV

Who this might be right for
HIV Infections
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 130
Early research (Phase 1)Study completedNCT02018510
What this trial is testing

A Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117

Who this might be right for
HealthyHIV
Rockefeller University 49
Post-approval studies (Phase 4)Study completedNCT00843713
What this trial is testing

Effect of Raltegravir on Endothelial Function in HIV-Infected Patients

Who this might be right for
HIV InfectionInflammationCardiovascular Disease+1 more
University of California, San Francisco 56
Not applicableStudy completedNCT04596488
What this trial is testing

Efavirenz 400mg in Treatment-naïve Chinese HIV-infected Patients

Who this might be right for
HIV-1-infection
Peking Union Medical College Hospital 25
Large-scale testing (Phase 3)Study completedNCT01227824
What this trial is testing

A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily

Who this might be right for
Infection, Human Immunodeficiency Virus I
ViiV Healthcare 828
Not applicableStudy completedNCT00164762
What this trial is testing

Nevirapine Resistance Study: Nevirapine Resistance Among HIV-Infected Mothers

Who this might be right for
HIV Infections
Centers for Disease Control and Prevention 126
Not applicableUnknownNCT03545217
What this trial is testing

Abnormal Glucose Metabolism in HIV-infected Patients

Who this might be right for
Abnormal Glucose Metabolism
Mahidol University 75
Testing effectiveness (Phase 2)Study completedNCT00052117
What this trial is testing

Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens

Who this might be right for
HIV Infections
Pfizer 300
Large-scale testing (Phase 3)Study completedNCT00146328
What this trial is testing

Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects

Who this might be right for
HIV Infections
Boehringer Ingelheim 997
Post-approval studies (Phase 4)Ended earlyNCT02322099
What this trial is testing

Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss

Who this might be right for
Bone Demineralization
University College Dublin 53
Not applicableStudy completedNCT00749580
What this trial is testing

A Pilot,Raltegravir Versus NRTIs as a Backbone Switched From a Stable Boosted PI Regimen

Who this might be right for
Virus DiseasesHIV
University of South Florida 46
Post-approval studies (Phase 4)Study completedNCT00966329
What this trial is testing

Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects

Who this might be right for
HIVHIV Infections
Germans Trias i Pujol Hospital 30
Testing effectiveness (Phase 2)Study completedNCT03639311
What this trial is testing

Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)-Positive Participants From the LATTE Study

Who this might be right for
HIV Infections
ViiV Healthcare 97
Early research (Phase 1)Study completedNCT00505401
What this trial is testing

Phase I Safety and Immunogenicity Vaccine Trial Against HIV/AIDS

Who this might be right for
HIV Infections
Istituto Superiore di Sanità 27
Post-approval studies (Phase 4)Study completedNCT01270802
What this trial is testing

Effects of Switching Efavirenz to Raltegravir on Vascular Function and Bone Markers in HIV-infected Patients

Who this might be right for
HIV
Indiana University 30
Not applicableStudy completedNCT00051519
What this trial is testing

Screening HIV-Infected Patients for Vaccine Studies

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 1,000
Not applicableStudy completedNCT00000844
What this trial is testing

A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 560
Next Page